[HTML][HTML] Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
The emergence of SARS-CoV-2 has created an international health crisis, and small animal
models mirroring SARS-CoV-2 human disease are essential for medical countermeasure …
models mirroring SARS-CoV-2 human disease are essential for medical countermeasure …
A mouse model of SARS-CoV-2 infection and pathogenesis
SH Sun, Q Chen, HJ Gu, G Yang, YX Wang… - Cell host & …, 2020 - cell.com
Since December 2019, a novel coronavirus SARS-CoV-2 has emerged and rapidly spread
throughout the world, resulting in a global public health emergency. The lack of vaccine and …
throughout the world, resulting in a global public health emergency. The lack of vaccine and …
The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus
ABSTRACT A comprehensive analysis and characterization of a severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection model that mimics non-severe and severe …
syndrome coronavirus 2 (SARS-CoV-2) infection model that mimics non-severe and severe …
SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice
The development of mouse models for coronavirus disease 2019 (COVID-19) has enabled
testing of vaccines and therapeutics and defining aspects of severe acute respiratory …
testing of vaccines and therapeutics and defining aspects of severe acute respiratory …
Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2
RD Jiang, MQ Liu, Y Chen, C Shan, YW Zhou… - Cell, 2020 - cell.com
COVID-19 has spread worldwide since 2019 and is now a severe threat to public health. We
previously identified the causative agent as a novel SARS-related coronavirus (SARS-CoV …
previously identified the causative agent as a novel SARS-related coronavirus (SARS-CoV …
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
FS Oladunni, JG Park, PA Pino, O Gonzalez… - Nature …, 2020 - nature.com
Vaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease
would benefit from validated small animal models. Here, we show that transgenic mice …
would benefit from validated small animal models. Here, we show that transgenic mice …
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
SARS-CoV-2 emerged in late 2019 and resulted in the ongoing COVID-19 pandemic.
Several animal models have been rapidly developed that recapitulate the asymptomatic to …
Several animal models have been rapidly developed that recapitulate the asymptomatic to …
Lung expression of human angiotensin-converting enzyme 2 sensitizes the mouse to SARS-CoV-2 infection
Preclinical mouse models that recapitulate some characteristics of coronavirus disease
(COVID-19) will facilitate focused study of pathogenesis and virus–host responses. Human …
(COVID-19) will facilitate focused study of pathogenesis and virus–host responses. Human …
[HTML][HTML] Evaluation of K18-hACE2 mice as a model of SARS-CoV-2 infection
Murine models of SARS-CoV-2 infection are critical for elucidating the biological pathways
underlying COVID-19. Because human angiotensin-converting enzyme 2 (ACE2) is the …
underlying COVID-19. Because human angiotensin-converting enzyme 2 (ACE2) is the …
COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice
C Lutz, L Maher, C Lee, W Kang - Human Genomics, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a declared pandemic that is spreading all
over the world at a dreadfully fast rate. Severe acute respiratory syndrome coronavirus-2 …
over the world at a dreadfully fast rate. Severe acute respiratory syndrome coronavirus-2 …
相关搜索
- sars cov transgenic mice
- respiratory disease transgenic mice
- sars cov severe disease
- sars cov human ace2
- severe disease human ace2
- sars cov k18 hace2
- sars cov lung infection
- severe disease lung infection
- respiratory disease k18 hace2
- sars cov covid 19
- respiratory disease covid 19
- sars cov respiratory disease
- sars cov lung expression
- sars cov infectious dose